Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.
The “2021 US Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and forecasts market performance over the next five years. The report includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
The first-edition “2020 Ophthalmic Landscape Report” offers a high-level analysis of the 2020 global ophthalmic market by region and specialty and forecasts market performance over the next five years. It discusses important trends and key factors for future success.
Market Scope has been meticulously tracking the effects of COVID-19 on the ophthalmic industry since the onset. After surveying US practices throughout 2020, we recently began surveying in Europe to better understand the impact on patient backlog, surgical procedures, adoption of technology, patient selection, and much more more. Our "2021 European COVID-19 Ophthalmic Practice Impact Survey Report" summarizes those findings for industry and surgeons to gain valuable insight into the markets' recovery.
The 2021 Retinal Surgical Device Market Report provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2021 market and forecasts market growth and evolution through 2026.
The 2021 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceuticals segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.
The “2020 Ophthalmic Deals Book” analyzes investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.
The report covers investments in ophthalmic ventures in 2020, with comparisons to 2018 and 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.
This report is a specialized supplement, expanding on the Glaucoma Diagnostics section of Market Scope’s comprehensive, global 2020 Ophthalmic Diagnostic Equipment Market Report. Market Scope segments the perimetry market to better understand the competitive landscape.
Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the perimetry market segments.
The report offers a comprehensive analysis of the 2020 global market for surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery.
Market Scope’s 2020 Refractive Error Model offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.
This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.
Market Scope’s 2020 European Five Ophthalmic Market Report analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 10 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.
In addition to our standard comprehensive reports, we also leverage our expert knowledge of the ophthalmic industry to design custom research that enhances strategy and operations for our clients. Our unique experience makes us a trusted partner in defining problems and executing solutions.
Common project types include custom data analysis, surveying and/or interviewing of ophthalmologists, focus groups, territory analyses, and other primary research initiatives -- but each project is custom designed to meet each specific clients' needs.
Please contact us for an individualized project consultation.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.